Compare BILL & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BILL | PTCT |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.0B |
| IPO Year | 2019 | 2006 |
| Metric | BILL | PTCT |
|---|---|---|
| Price | $61.45 | $56.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 21 | 15 |
| Target Price | $62.93 | ★ $100.47 |
| AVG Volume (30 Days) | ★ 1.9M | 939.5K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | ★ 0.61 | 0.34 |
| Revenue | ★ $1,653,160,000.00 | $264,734,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.79 | $8.29 |
| P/E Ratio | ★ $105.05 | $171.44 |
| Revenue Growth | 13.03 | ★ 36.19 |
| 52 Week Low | $31.41 | $58.15 |
| 52 Week High | $66.58 | $90.87 |
| Indicator | BILL | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 68.40 | 33.38 |
| Support Level | $41.09 | N/A |
| Resistance Level | N/A | $69.74 |
| Average True Range (ATR) | 2.73 | 2.50 |
| MACD | 1.07 | -0.78 |
| Stochastic Oscillator | 72.04 | 1.01 |
BILL Holdings Inc is the intelligent finance platform trusted by nearly half a million businesses and their accountants to manage, move, and maximize their money. It powers businesses ranging from fast-moving startups to growing companies with complex operations. It use artificial intelligence (AI) to deliver strategic finance capabilities in one integrated platform that includes accounts payable (AP), accounts receivable (AR), expenses, forecasting, procurement, and more. The company operates as one operating segment. Its products are Accounts Payable, Accounts Receivable, Accountant Console, Pay By Card, ACH Payments, International Payments, Invoicing, Approvals, Integrations, Controls, Mobile App, and Security. Its solutions are Construction, Education, Healthcare, Hospitality, etc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.